Nilda Mesa is Director at UNITED THERAPEUTICS Corp (UTHR). They have made 13 open-market trades across 1 company since 2022, most recently 2026-09-14.
CIK 0001756697
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| UTHR | 5,580 | $3.4M |
Shares reported on the most recent Form 4, priced at the 2026-09-15 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UTHR | SELL | 2026-09-14 | 2026-09-15 | $505.87 | $115K | -5.6% | +7.6% | — |
| UTHR | SELL | 2026-05-12 | 2026-05-13 | $581.94 | $150K | -0.1% | -5.7% | -11.1% |
| UTHR | SELL | 2025-12-09 | 2025-12-10 | $481.63 | $180K | +6.4% | +0.1% | +10.9% |
| UTHR | SELL | 2025-06-24 | 2025-06-25 | $289.99 | $374K | +2.2% | +5.7% | +50.6% |
| UTHR | SELL | 2024-12-30 | 2024-12-31 | $355.77 | $181K | +3.5% | -0.0% | -12.5% |
| UTHR | SELL | 2024-11-08 | 2024-11-12 | $412.28 | $185K | -6.8% | -9.6% | -13.6% |
| UTHR | SELL | 2024-06-25 | 2024-06-26 | $318.58 | $169K | +1.7% | +6.6% | +12.8% |
| UTHR | SELL | 2024-03-27 | 2024-03-29 | $237.80 | $77K | +4.3% | +4.5% | +39.0% |
| UTHR | SELL | 2023-12-19 | 2023-12-20 | $244.90 | $296K | +1.0% | -3.6% | +6.0% |
| UTHR | SELL | 2023-09-13 | 2023-09-15 | $222.36 | $170K | +5.2% | +5.4% | +15.0% |
| UTHR | SELL | 2023-05-05 | 2023-05-08 | $214.81 | $161K | +3.3% | +5.2% | +13.4% |
| UTHR | SELL | 2022-11-07 | 2022-11-07 | $268.57 | $156K | -0.1% | +4.5% | -3.7% |
| UTHR | SELL | 2022-09-28 | 2022-09-30 | $210.35 | $442K | -0.1% | +9.0% | +30.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.